Clinical Editor's Corner: Kern

January 3, 2018
Stimulated by a couple of recent articles on the efficiency of the RADPAD protection drape in reducing operator’s exposure1 and the effects of shielding on nurses and technologists in the cath lab2, I thought it would be a good idea to see what was new and what we should be thinking about to reduce radiation exposure to ourselves, our team, and our patients.  
December 6, 2017
Many of the editor’s pages come from issues raised by practicing interventionalists. Recently, a query came to our colleague, Dr. Zoltan Turi, from a chief of cardiology.
November 6, 2017
Given the infrequency with which we perform TSP, I asked my expert cath lab colleagues about the need for more heparin in TSP for only diagnostic purposes. In addition, I also asked, “Does the anticoagulation regimen differ for each type of procedure? Do we need to ever worry about too much anticoagulation since the electrophysiology (EP) operators do TSPs even with high INR values?”
October 6, 2017
In this editor’s page, our colleague Dr. Sam Butman asks our group of cath lab experts, “What is your approach to a patient admitted with new-onset congestive heart failure (CHF) without recent myocardial infarction or angina?”
July 11, 2017
The PA pressure sensor technology now is simple and easily implemented in the cath lab. Caveats aside, this looks like a game changer for our patients with difficult-to-manage CHF.
June 8, 2017
This year, the Society for Cardiovascular Angiography and Interventions (SCAI) celebrated the “40 for 40” event; that is, the 40th anniversary of percutaneous coronary intervention and the 40th anniversary year of the founding of the SCAI. On May 11, 2017, I was honored to be the Frank Hildner Annual Lectureship speaker.
May 1, 2017
iFR is non-inferior to FFR and associated with fewer stents/CABG procedures. However, compared to FFR, there are no long-term outcome or independent ischemic testing validation data. Currently, FFR remains the comparative standard for iFR.
April 11, 2017
For patients in cardiogenic shock, LV mechanical support, depending on the hemodynamic profile of the device, can restore and support the systemic circulation, an especially beneficial effect if instituted early, an action that may improve shock mortality. 
March 7, 2017
We prescribe these drugs to reduce the rates of stent-related thrombosis in both the short and long term, and we must weigh the risk of stent thrombosis against the risk of bleeding. This balancing act is not always straightforward.
February 8, 2017
Every cardiac cath lab around the world is staffed with hardworking men and women of various backgrounds, experiences, education, and work ethics. Every lab strives to be its best at all times. Each team member has the opportunity (or should have) to contribute to making their lab, “the best that it can be” (forgive my borrowing an expression from our U.S. Army).